A man with recurrent hypovolemic shock on anti-programmed cell death protein 1 treatment: Immune-related protein-losing enteropathy

被引:3
|
作者
Lee, Seo Young [1 ]
Kim, Min Hwan [1 ]
Jang, Mi [2 ]
Park, Yehyun [3 ]
Cho, Byoung Chul [1 ]
机构
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol,Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea
关键词
D O I
10.1016/j.ejca.2018.09.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:104 / 107
页数:4
相关论文
共 50 条
  • [1] Immunogenomic correlates of immune-related adverse events for anti-programmed cell death 1 therapy
    Zhang, Lei
    Shi, Yuankai
    Han, Xiaohong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Bullous dermatoses as immune-related adverse effects of anti-programmed cell death protein 1 immunotherapy: a case of lichen planus pemphigoides
    Patel, P.
    Kawsar, A.
    Harwood, C.
    Markiewicz, D.
    Szolsarek, P.
    Phillips, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : E150 - E151
  • [3] Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy
    Tang, Kimberly
    Seo, Jayhyun
    Tiu, Bruce C.
    Le, Thomas K.
    Pahalyants, Vartan
    Raval, Neel S.
    Ugwu-Dike, Pearl O.
    Zubiri, Leyre
    Naranbhai, Vivek
    Carrington, Mary
    Gusev, Alexander
    Reynolds, Kerry L.
    LeBoeuf, Nicole R.
    Asgari, Maryam M.
    Kwatra, Shawn G.
    Semenov, Yevgeniy R.
    JAMA DERMATOLOGY, 2022, 158 (02) : 189 - 193
  • [4] Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies
    Bernard-Tessier, Alice
    Jeanville, Priscilla
    Champiat, Stephane
    Lazarovici, Julien
    Voisin, Anne-Laure
    Mateus, Christine
    Lambotte, Olivier
    Annereau, Maxime
    Michot, Jean-Marie
    EUROPEAN JOURNAL OF CANCER, 2017, 81 : 135 - 137
  • [5] Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-Programmed Cell Death Ligand 1 Therapy: A Case Series
    Yun, Jenny Sung Won
    Chan, Louis
    Goh, Michelle
    McCormack, Chris
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 18 - 18
  • [6] Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature
    Tsiogka, Aikaterini
    Bauer, Johann W.
    Patsatsi, Aikaterini
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 1 - 7
  • [7] Cardiac and Nephrological Complications Related to the Use of Antiangiogenic and Anti-Programmed Cell Death Protein 1 Receptor/Programmed Cell Death Protein 1 Ligand Therapy
    Stachyra-Strawa, Paulina
    Szatkowska-Sieczek, Lidia
    Cisek, Pawel
    Golebiowski, Pawel
    Grzybowska-Szatkowska, Ludmila
    GENES, 2024, 15 (02)
  • [8] Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
    Mekki, Ahmed
    Dercle, Laurent
    Lichtenstein, Philip
    Marabelle, Aurelien
    Michot, Jean-Marie
    Lambotte, Olivier
    Le Pavec, Jerome
    De Martin, Eleonora
    Balleyguier, Corinne
    Champiat, Stephane
    Ammari, Samy
    EUROPEAN JOURNAL OF CANCER, 2018, 96 : 91 - 104
  • [9] Multiple immune-related toxicities in cancer patients treated with anti-programmed cell death protein 1 immunotherapies: a new surrogate marker for clinical trials?
    Laparra, A.
    Kfoury, M.
    Champiat, S.
    Danlos, F. X.
    Martin-Romano, P.
    Simonaggio, A.
    Baldini, C.
    Vuagnat, P.
    Mateus, C.
    Voisin, A. L.
    Albiges, L.
    Besse, B.
    Even, C.
    Robert, C.
    Laghouati, S.
    Massard, C.
    Marabelle, A.
    Lambotte, O.
    Michot, J. M.
    ANNALS OF ONCOLOGY, 2021, 32 (07) : 936 - 937
  • [10] Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
    Vitale, Giovanni
    Lamberti, Giuseppe
    Comito, Francesca
    Di Nunno, Vincenzo
    Massari, Francesco
    Morelli, Maria Cristina
    Ardizzoni, Andrea
    Gelsomino, Francesco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (09) : 1047 - 1059